Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam P Bress

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Infectious Diseases and Therapy|March 2, 2018
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Joel Myers, et al.
Hypertension (Dallas, Tex. : 1979)|July 20, 2016
Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012Gabriel S Tajeu, Shia T Kent, Ian M Kronish, et al.
Clinical Trials (London, England)|April 20, 2018
A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomesSong Yang, Walter T Ambrosius, Lawrence J Fine, et al.
Hypertension (Dallas, Tex. : 1979)|October 18, 2022
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular EventsLeo F Buckley, William L Baker, Benjamin W Van Tassell, et al.
Hypertension (Dallas, Tex. : 1979)|April 5, 2021
Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and HypertensionLeah B Rethy, Matthew J Feinstein, Chad J Achenbach, et al.
Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.
Circulation. Cardiovascular Quality and Outcomes|February 8, 2024
Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United StatesGabriel S Tajeu, Natalia Ruiz-Negrón, Andrew E Moran, et al.
JAMA|February 9, 2026
Impact of a Smartwatch Hypertension Notification Feature for Population ScreeningJordana B Cohen, Daniel K Addo, Joshua A Jacobs, et al.
Circulation Research|June 5, 2020
Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"Jordana B Cohen, Thomas C Hanff, Andrew M South, et al.
Journal of the American Heart Association|August 14, 2019
Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart StudyD Edmund Anstey, Rikki M Tanner, John N Booth, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Infectious Diseases and Therapy|March 2, 2018
Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant AntiretroviralsJoanne LaFleur, Adam P Bress, Joel Myers, et al.
Hypertension (Dallas, Tex. : 1979)|July 20, 2016
Trends in Antihypertensive Medication Discontinuation and Low Adherence Among Medicare Beneficiaries Initiating Treatment From 2007 to 2012Gabriel S Tajeu, Shia T Kent, Ian M Kronish, et al.
Clinical Trials (London, England)|April 20, 2018
A new modeling and inference approach for the Systolic Blood Pressure Intervention Trial outcomesSong Yang, Walter T Ambrosius, Lawrence J Fine, et al.
Hypertension (Dallas, Tex. : 1979)|October 18, 2022
Systolic Blood Pressure Time in Target Range and Major Adverse Kidney and Cardiovascular EventsLeo F Buckley, William L Baker, Benjamin W Van Tassell, et al.
Hypertension (Dallas, Tex. : 1979)|April 5, 2021
Antihypertensive Class and Cardiovascular Outcomes in Patients With HIV and HypertensionLeah B Rethy, Matthew J Feinstein, Chad J Achenbach, et al.
Pharmacotherapy|February 4, 2016
Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical CenterAdam P Bress, Jordan B King, Diana Brixner, et al.
Circulation. Cardiovascular Quality and Outcomes|February 8, 2024
Cost of Cardiovascular Disease Event and Cardiovascular Disease Treatment-Related Complication Hospitalizations in the United StatesGabriel S Tajeu, Natalia Ruiz-Negrón, Andrew E Moran, et al.
JAMA|February 9, 2026
Impact of a Smartwatch Hypertension Notification Feature for Population ScreeningJordana B Cohen, Daniel K Addo, Joshua A Jacobs, et al.
Circulation Research|June 5, 2020
Response by Cohen et al to Letter Regarding Article, "Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19"Jordana B Cohen, Thomas C Hanff, Andrew M South, et al.
Journal of the American Heart Association|August 14, 2019
Inappropriate Left Ventricular Mass and Cardiovascular Disease Events and Mortality in Blacks: The Jackson Heart StudyD Edmund Anstey, Rikki M Tanner, John N Booth, et al.
Pageof 16